Setting a standard for a "silent" disease: Defining osteoporosis in the 1980s and 1990s

Studies in History and Philosophy of Science Part C :Studies in History and Philosophy of Biological and Biomedical Sciences

Volumn 41, Issue 4, 2010, Pages 376-385

  Wylie, Caitlin Donahue ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Disease definition; Medical imaging; Osteoporosis; Risk factor; Standardization; World Health Organization

Indexed keywords

ARTICLE; BONE DENSITY; CLASSIFICATION; DIAGNOSTIC IMAGING; HISTORY; HUMAN; INTERNATIONAL COOPERATION; METHODOLOGY; OSTEOPOROSIS; PATHOLOGY; RISK; WORLD HEALTH ORGANIZATION;

BONE DENSITY; DIAGNOSTIC IMAGING; HISTORY, 20TH CENTURY; HUMANS; INTERNATIONAL COOPERATION; OSTEOPOROSIS; RISK; WORLD HEALTH ORGANIZATION;

EID: 78649629971     PISSN: 13698486     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.shpsc.2010.10.015     Document Type: Article

References (78)

1. Adams, J. E. (1995). Quantitative measurements in osteoporosis. In F. Tovey, & T. C. B. Stamp (Eds.), The measurement of metabolic bone disease (pp. 107-142). London: Parthenon Publishing Group.
2. Albright F., Bloomberg E., Smith P. Post-menopausal osteoporosis. Transactions of the Association of American Physicians 1940, 55:298-305.
3. Albright F., Smith P., Richardson A. Postmenopausal osteoporosis: Its clinical features. Journal of the American Medical Association 1941, 116:2465-2474.
4. Albright F., Reifenstein E.C. Parathyroid glands and metabolic bone sisease 1948, Williams & Wilkins, Baltimore, MD.
5. Anderson J., Neary F., Pickstone J.V. Surgeons, manufacturers and patients: A transatlantic history of total hip replacement 2007, Palgrave Macmillan, Hampshire.
6. Anon. Consensus development conference. prophylaxis and treatment of osteoporosis. British Medical Journal 1987, 295:914-915.
7. Anon. Consensus development conference: Prophylaxis and treatment of osteoporosis. Journal of American Medical Association 1991, 90:107-110.
8. Anon. Consensus development conference: Diagnosis, prophylaxis, and treatment of osteoporosis. American Journal of Medicine 1993, 94:646-650.
9. Aronowitz R.A. Making sense of illness: Science, society, and disease 1998, Cambridge University Press, Cambridge.
10. Azria M. The value of biomarkers in detecting alterations in bone metabolism. Calcified Tissue International 1989, 45:7-11.
11. Blake, G. Personal communication, 12 March 2009.
12. Cameron J.R., Sorenson J.A. Measurement of bone mineral in vivo: An improved method. Science 1963, 142:230-232.
13. Churchill's Illustrated Medical Dictionary. (1989). New York, NY: Churchill Livingstone.
14. Colman E., Hedin R., Swann J., Orloff D. A brief history of calcitonin. Lancet 2002, 359:885-886.
15. Cummings S.R., Black D. Should perimenopausal women be screened for osteoporosis?. Annals of Internal Medicine 1986, 104:817-823.
16. Dorland W.A.N. Dorland's illustrated medical dictionary 1994, W. B. Saunders Company, New York, NY. 28th ed.
17. European Calcified Tissue Society. Calcified tissue international. (Accessed 4 March 2009). http://www.ectsoc.org/journal.htm.
18. Fogelman I. The case for routine bone mass measurements. Nuclear Medicine Communications 1988, 9:541-543.
19. Fogelman I. Bone loss: A massive health problem. MIMS Magazine 1988, 15 June:90-96.
20. Fogelman I. An evaluation of the contribution of bone mass measurements to clinical practice. Seminars in Nuclear Medicine 1989, 19:62-68.
21. Forbes A. Fuller Albright: His concept of postmenopausal osteoporosis and hat came of it. Clinical Orthopaedics and Related Research 1991, 269:128-141.
22. Freemont, A. H. (1995). Bone histomorphometry. In F. Tovey, & T. C. B. Stamp (Eds.), The measurement of metabolic bone disease (pp. 77-90). London: Parthenon Publishing Group.
23. Goodwin P.N. Methodologies for the measurement of bone density and their precision and accuracy. Seminars in Nuclear Medicine 1987, 17:293-304.
24. Gould's Medical Dictionary. (1972). 3rd ed. New York, NY: McGraw-Hill.
25. Gould's Medical Dictionary (1979). 4th ed. New York, NY: McGraw-Hill.
26. Greene J.A. Prescribing by numbers: Drugs and the definition of disease 2007, Johns Hopkins University Press, Baltimore, MD.
27. Hansen, B. (1992). American physicians' 'discovery' of homosexuals 1890-1900: a new diagnosis in a changing society. In C. Rosenberg, & J. Goldman (Eds.), Framing disease: studies in cultural history (pp. 104-133). New Jersey: Rutgers University Press.
28. Bone mineral densitometry. Annals of Internal Medicine 1987, 107:932-936. Health and Public Policy Committee, American College of Physicians.
29. International Directory of Company Histories. (1999).Company Histories: Lunar Corporation. (Vol. 29) Farmington Hills, MI: St. James Press. (Accessed 4 March 2009). http://www.fundinguniverse.com/company-histories/Lunar-Corporation-Compa ny-History.html.
30. Jensen F.G., McNair P., Boesen J., Hegedus V. Validity in diagnosing osteoporosis. European Journal of Radiology 1984, 4:1-3.
31. Johnston, C. C., & Melton, L. J. (1995). Bone densitometry. In B. L. Riggs, & L. J. Melton (Eds.), Osteoporosis: etiology, diagnosis, and management (2nd ed.) (pp. 275-298). Philadelphia: Lippincott-Raven Publishers.
32. Journal of Bone and Mineral Research. American Society for Bone and Mineral Research. (Accessed 4 March 2009). http://www.jbmronline.org.
33. Kanis J.A. Editorial: Osteoporosis and osteopenia. Journal of Bone and Mineral Research 1990, 5:209-211.
34. Kanis J.A. Textbook of osteoporosis 1996, Blackwell Sciences Ltd., London.
35. Kanis, J. A. Personal communication, 11 March 2009.
36. Kanis J.A., Study Group W.H.O. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: Synopsis of a WHO report. Osteoporosis International 1994, 4:368-381.
37. Kanis J.A., Caulin F., Russell R.G.G. Problems in the design of clinical trials in osteoporosis. Osteoporosis, a multi-disciplinary problem 1983, 205-221. Academic Press Inc., London. A.S.J. Dixon, R.G.G. Russell, T.C.B. Stamp (Eds.).
38. Kanis J.A., Devogulaer J.P., Gennari C. Practical guide for the use of bone mineral measurements in the assessment of treatment of osteoporosis: A position paper of the European Foundation for Osteoporosis and Bone Disease. Osteoporosis International 1996, 6:256-261.
39. Kanis J.A., Melton L.J., Christiansen C., Johnston C.C., Khaltaev N. The diagnosis of osteoporosis. Journal of Bone and Mineral Research 1994, 9:1137-1141.
40. Kevles B. Naked to the bone 1997, Rutgers University Press, New Brunswick, NJ.
41. Kimmel D.B., Recker R.R. Clinical assessments of bone strength. Osteoporosis 1994, 49-68. Blackwell Scientific Publications, Oxford. R. Marcus (Ed.).
42. Latour B. Science in action: How to follow scientists and engineers through society 1987, Harvard University Press, Cambridge, MA.
43. Mazess R.B. Bone density in diagnosis of osteoporosis: Thresholds and breakpoints. Calcified Tissue International 1987, 41:117-118.
44. Melton L.J., Wahner H.W. Defining osteoporosis. Calcified Tissue International 1989, 45:263-264.
45. Melton L.J., Chrischilles E.A., Cooper C., Lane A.W., Riggs B.L. Perspective: How many women have osteoporosis?. Journal of Bone and Mineral Research 1992, 7:1005-1010.
46. Melton, L. J. Personal communication, 11 March 2009.
47. Milhaud G. First therapeutic use of calcitonin. Bone and Mineral 1992, 16:201-210.
48. Mughal Z. Reference data for bone density and body composition measured with dual energy x-ray absorptiometry in white children and young adults. Archives of Disease in Childhood 2002, 87:341-347.
49. Nordin B.E.C. The definition and diagnosis of osteoporosis. Calcified Tissue International 1987, 40:57-58.
50. O'Connell J. Metrology: the creation of universality by the circulation of particulars. Social Studies of Science 1993, 23:129-173.
51. Odvina C.V., Wergedal J.E., Libanati E.E., Schultz E.E., Baylink D.J. Relationship between trabecular vertebral body density and fractures: A quantitative definition of spinal osteoporosis. Metabolism 1988, 37:221-228.
52. Oxford Reference Concise Medical Dictionary. (1995). 4th ed. Oxford: Oxford University Press.
53. Peitzman, S. J. (1992). From Bright's disease to end-stage renal disease. In C. Rosenberg, & J. Goldman (Eds.), Framing disease: studies in cultural history (pp. 3-19). New Jersey, NJ: Rutgers University Press.
54. Our bodies ourselves 1978, Penguin Books, New York, NY. A. Phillips, J. Rakusen (Eds.).
55. New our bodies ourselves 1989, Penguin Books, London. A. Phillips, J. Rakusen (Eds.).
56. Riggs L.B. Overview of osteoporosis. The Western Journal of Medicine 1991, 154:63-77.
57. Osteoporosis: Etiology, diagnosis, and management 1995, Lippincott-Raven Publishers, Philadelphia. 2nd ed. L.B. Riggs, L.J. Melton (Eds.).
58. Riggs L.B., Wahner H.W. Bone densitometry and clinical decision-making in osteoporosis. Annals of Internal Medicine 1988, 108:293-295.
59. Rosenberg, C. E. (1992). Framing disease: illness, society, and history. In C. Rosenberg, & J. Goldman (Eds.), Framing disease: studies in cultural history (pp. xiii-xxvi). New Jersey, NJ: Rutgers University Press.
60. Ross P.D., Yhee Y.K., Yi-Fan H., Davis J.W., Kamimoto C., Epstein R.S., Wasnich R.D. A new method for vertebral fracture diagnosis. Journal of Bone and Mineral Research 1993, 8:167-174.
61. Rothery B. Standards and certification in Europe 1996, Gower Publishing Ltd., Hampshire, England.
62. Schaffer S. Late Victorian metrology and its instrumentation: A manufactory of ohms. The science studies reader 1998, 457-478. Routledge, London. M. Biagioli (Ed.).
63. Shapira D., Shapira C. Osteoporosis: The evolution of a scientific term. Osteoporosis International 1992, 2:164-167.
64. Sinding C. Making the unit of insulin: Standards, clinical work, and Industry, 1920-1925. Bulletin of the History of Medicine 2002, 76:231-270.
65. Timmermann C. A matter of degree: The normalization of hypertension, c. 1940-2000. Histories of the normal and the abnormal: social and cultural histories of norms and normativity 2006, 245-261. Routledge, London. W. Ernst (Ed.).
66. Timmermann, C. (2006b). To treat or not to treat: drug research and the changing nature of essential hypertension. In T. Schlich, & U. Trohler (Eds.), The tisks of medical innovation: Risk perception and assessment in historical context (pp. 133-147). London: Routledge.
67. The measurement of metabolic bone disease 1995, Parthenon Publishing Group, London. F. Tovey, T.C.B. Stamp (Eds.).
68. Bone health and osteoporosis: A report of the surgeon general 2004, U. S. Department of Health and Human Services, U. S. Department of Health and Human Services, Office of the Surgeon General, Rockville, MD.
69. Wailoo K. Drawing blood: Technology and disease identity in twentieth-century America 1997, Johns Hopkins University Press, Baltimore, MD.
70. Wasserman S.H.S., Barzel U.S. Osteoporosis: The state of the art in 1987: A review. Seminars in Nuclear Medicine 1987, 17:283-292.
71. Watkins E.S. The estrogen elixir: A history of hormone replacement therapy in America 2007, Johns Hopkins University Press, Baltimore, MD.
72. Woolf A.D. Osteoporosis: whose problem is it?. Annals of the Rheumatic Diseases 1992, 51:130-133.
73. World Health Organization. (1994). Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. report of a WHO study group. WHO Technical Report Series, 843. Geneva: World Health Organization. http://whqlibdoc.who.int/trs/who_trs_843.pdf.
74. World Health Organization Expert Committee on Biological Standardization (1994). 44th Report. WHO Technical Report Series, 848. Geneva: World Health Organization. http://whqlibdoc.who.int/trs/who_trs_848.pdf.
75. World Health Organization. (2003). Prevention and management of osteoporosis: report of a WHO dcientific group. WHO Technical Report Series, 921. Geneva: World Health Organization. http://whqlibdoc.who.int/trs/who_trs_921.pdf.
76. World Health Organization (2006). Constitution of the World Health Organization. First issued 22 July 1946. 45th ed. Geneva: World Health Organization. (Accessed 10 March 2009). http://www.who.int/governance/eb/constitution/en/.
77. World Health Organization (2009). WHO Expert Committee on Biological Standardization. Geneva: World Health Organization. (Accessed 10 March 2009). http://www.who.int/biologicals/expert_committee/en/.
78. Young C.G., Berger J.D. Medical specialty terminology: Pathology, clinical cytology, and clinical pathology 1971, C. V. Mosby Co, St. Louis.